UHS Universal Health Services
Steady hospital and behavioral franchise priced for a policy cliff its margins can mostly absorb.
The story
UHS runs two franchises: acute-care hospitals in fast-growing Sun Belt markets and the largest US behavioral health network, where scarce licensed beds and certificate-of-need barriers protect pricing. It is a mature, cash-generative business growing mid-single digits, with margins lifted by labor normalization and state supplemental payments. The main threat is Medicaid policy (phase-down of state-directed payments and provider taxes from 2028), not competitive erosion.
No material facts changed: TTM revenue grew about 6% and TTM margin of 11.5% matches my prior target, which sits below the 12.2% FY peak to absorb supplemental-payment cuts and payer-mix pressure. Sales-to-capital nudges from 1.48 to 1.50 to reflect TTM 1.53, and a 7-year horizon fits a mature hospital operator.
Value drivers
| Revenue growth (Y1) | 6.0% |
| Terminal growth | 2.5% |
| Forecast horizon | 7y |
| Target operating margin | 11.5% |
| Years to target margin | 3 |
| Sales-to-capital | 1.50 |
| Beta | 1.00 |
| Failure probability | 1.0% |
| Cost of capital (WACC) | 8.3% |
| Terminal WACC | 8.3% |
Valuation bridge
| PV of explicit FCFF | 6.84B |
| PV of terminal value | 17.75B |
| Equity value | 19.64B |
| ÷ shares → per share | $340.62 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 19.45B | 6.0% | 11.5% | 1.72B | 734.10M | 982.59M | 907.15M |
| 2 | 20.51B | 5.4% | 11.5% | 1.81B | 702.50M | 1.11B | 942.61M |
| 3 | 21.50B | 4.8% | 11.5% | 1.89B | 660.80M | 1.23B | 970.78M |
| 4 | 22.41B | 4.2% | 11.5% | 1.97B | 609.13M | 1.37B | 992.28M |
| 5 | 23.23B | 3.7% | 11.5% | 2.05B | 547.86M | 1.50B | 1.01B |
| 6 | 23.95B | 3.1% | 11.5% | 2.11B | 477.59M | 1.63B | 1.01B |
| 7 | 24.55B | 2.5% | 11.5% | 2.16B | 399.18M | 1.76B | 1.01B |
Key risks
- Medicaid supplemental payment and provider-tax phase-downs cut high-margin revenue from 2028
- Exchange subsidy expiry raises uninsured volume and bad debt
- Labor cost reinflation and behavioral-health litigation verdicts
Catalysts
- Continued buybacks at a low EBIT multiple shrink share count
- Behavioral volume recovery and new acute capacity (DC, Florida) ramping to mature margins